Structure-activity relationships of novel anti-malarial agents.: Part 3:: N-(4-acylamino-3-benzoylphenyl)-4-propoxycinnamic acid amides

被引:32
|
作者
Wiesner, J
Kettler, K
Jomaa, H
Schlitzer, M
机构
[1] Univ Munich, Zentrum Pharmaforsch, Dept Pharm, D-81377 Munich, Germany
[2] Univ Giessen Klinikum, Biochem Inst, D-35249 Giessen, Germany
[3] Jomaa Pharm GmbH, D-35249 Giessen, Germany
关键词
D O I
10.1016/S0960-894X(01)00798-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have described 5-(4-propoxycinnamoylamino)-2-(4-tolylacetylamino)benzophenone 6e as a novel lead for antimalarial agents. Anti-malarial activity of these 5-(4-propoxycinnamoylamino)benzophenones proved to be quite sensitive against variations of the acyl substituent at the 2-amino group. Best activity was obtained with phenylacetic acid moieties carrying small substituents in the para-position. From the para-substituents evaluated, the trifluoromethyl group yielded the most active compound (6j) in this series (IC50 = 120 nM). Deviations from the phenylacetic acid substructure, shifting the substituent into the ortho-position or bulkier para-substituents resulted in a significant reduction in anti-malarial activity. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:543 / 545
页数:3
相关论文
共 50 条
  • [1] Structure-activity relationships of novel anti-malarial agents:: Part 5.: N-(4-acylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides
    Wiesner, J
    Kettler, K
    Sakowski, J
    Ortmann, R
    Jomaa, H
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 361 - 363
  • [2] Structure-activity relationships of novel anti-malarial agents.: Part 6:: N-(4-arylpropionylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides
    Wiesner, J
    Fucik, K
    Kettler, K
    Sakowski, J
    Ortmann, R
    Jomaa, H
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (09) : 1539 - 1541
  • [3] Structure-activity relationships of novel anti-malarial agents.: Part 4:: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amides
    Wiesner, J
    Mitsch, A
    Wissner, P
    Krämer, O
    Jomaa, H
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (19) : 2681 - 2683
  • [4] Structure-activity relationships of novel anti-malarial agents. Part 2: Cinnamic acid derivatives
    Wiesner, J
    Mitsch, A
    Wissner, P
    Jomaa, H
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (03) : 423 - 424
  • [5] Structure-activity relationships of novel anti-malarial agents.: Part 7:: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-uryl)acrylic acid amides with polar moieties
    Wiesner, J
    Mitsch, A
    Jomaa, H
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (13) : 2159 - 2161
  • [6] Non-thiol farnesyltransferase inhibitors:: N-(4-acylamino-3-benzoylphenyl)-4-nitrocinnamic acid amides
    Sakowski, J
    Sattler, I
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (02) : 233 - 239
  • [7] Non-thiol farnesyltransferase inhibitors:: N-(4-acylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides
    Kettler, K
    Sakowski, J
    Silber, K
    Sattler, I
    Klebe, G
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (07) : 1521 - 1530
  • [8] Structure-activity relationships of novel anti-malarial agents part 8.: Effect of different central aryls in biarylacryloylaminobenzophenones on antimalarial activity
    Wiesner, J
    Mitsch, A
    Altenkämper, M
    Ortmann, R
    Jomaa, H
    Schlitzer, M
    PHARMAZIE, 2003, 58 (12): : 854 - 856
  • [9] Non-thiol farnesyltransferase inhibitors:: N-(4-tolylacetylamino3-benzoylphenyl)-3-arylfurylacrylic acid amides
    Mitsch, A
    Wissner, P
    Silber, K
    Haebel, P
    Sattler, I
    Klebe, G
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (17) : 4585 - 4600
  • [10] Structure-activity relationships of novel anti-malarial agents: 1. arylacyl and cyclohexylacyl derivatives of 5-amino-2-tolylacetylaminobenzophenone
    Wiesner, J
    Mitsch, A
    Wissner, P
    Jomaa, H
    Schlitzer, M
    PHARMAZIE, 2001, 56 (06): : 443 - 444